Nls pharmaceutics to participate in the micro cap rodeo fall harvest conference: best ideas from the buy-side

Stans, switzerland / accesswire / september 30, 2021 / nls pharmaceutics ltd. (nasdaq:nlsp, nlspw) ("nls" or the "company"), a swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces that its chief executive officer and co-founder alex zwyer is scheduled to present a corporate overview and meet with investors at the micro cap rodeo fall harvest conference to be held virtually october 5-8, 2021.
NLSP Ratings Summary
NLSP Quant Ranking